Kazuhide Iwasaki - Concepedia

Author

Kazuhide Iwasaki

Showa Pharmaceutical University

Also Known As

Iwasaki Kazuhide, KAZUHIDE IWASAKI, Kazuhide IWASAKI, Kazuhide Iwasaki

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Showa Pharmaceutical University Shin Nippon Biomedical Laboratories (Japan)Mochida Pharmaceutical (Japan)Novartis (Japan)Pfizer (Japan)

About

Kazuhide Iwasaki is an author at Showa Pharmaceutical University specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	20	906
2	Biochemistry	14	17	650
3	Health Sciences	5	5	226
4	Natural Sciences	4	4	165
5	Allergy	1	1	15

Kazuhide Iwasaki

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Neuroprotective Actions of FK506 in Experimental Stroke:<i>In Vivo</i>Evidence against an Antiexcitotoxic Mechanism Steven P. Butcher, David C. Henshall, Yoshinori TERAMURA, Journal of Neuroscience Neuroprotective ActionsNitric OxideCell DeathCerebral Vascular RegulationNeuroinflammation	1997	218
Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes Toshipumi Shiraga, Hiroji Matsuda, Kazuko Nagase, Biochemical Pharmacology Cytochrome P450 3ABiochemistryMedicineLiver PhysiologyHepatotoxicity	1994	130
Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes Kazuko Nagase, Kazuhide Iwasaki, Katsuko Nozaki, Journal of Pharmacy and Pharmacology ImmunologyBlood CellCell DeathImmunologic MechanismImmunotherapy	1994	115
EXPRESSION OF HUMAN CYTOCHROMES P450 IN CHIMERIC MICE WITH HUMANIZED LIVER Miki Katoh, Tomohito Matsui, Miki Nakajima, Drug Metabolism and Disposition	2004	114
In Vitro Inhibitory Effect of 1-Aminobenzotriazole on Drug Oxidations Catalyzed by Human Cytochrome P450 Enzymes: A Comparison with SKF-525A and Ketoconazole Chie Emoto, Shigeo Murase, Yasufusa Sawada, Drug Metabolism and Pharmacokinetics	2003	111
Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (<i>SLCO2B1</i>), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose Ichiro Ieiri, Yohei Doi, Kazuya Maeda, The Journal of Clinical Pharmacology	2011	105
IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER Miki Katoh, Tomohito Matsui, Miki Nakajima, Drug Metabolism and Disposition	2005	57
Reduction of Tertiary Amine N-Oxides by Liver Microsomal Cytochrome P-450 Masahiko Sugiura, Kazuhide Iwasaki, Ryuichi Kato Molecular Pharmacology	1976	57
Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction Masahiko Sugiura, Kazuhide Iwasaki, Hideyo Noguchi, Life Sciences Molecular PharmacologyMedicinal ChemistryTiaramide N-oxide ReductionBiochemistryReactive Nitrogen Specie	1974	52
Relationship between chemical structure and activity. I. Effects of the number of chlorine atoms in chlorinated benzenes on the components of drug-metabolizing system and the hepatic constituents. TOSHIHIKO ARIYOSHI, KATSUMI IDEGUCHI, Yasuhiro Ishizuka, Chemical and Pharmaceutical Bulletin δ-Aminolevulinic Acidδ-Ala SynthetaseChemistryToxicological MechanismMolecular Pharmacology	1975	48

Page 1